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1 
INTRODUCTION 
Atrial fibrillation is a condition of increasing clinical and economic 
importance.It is the most common arrhythmia encountered in clinical 
practice.AF is a supraventricular tachyarrhythmia characterized by 
uncoordinated atria activation with consequent deterioration of atrial 
mechanical function. 
Atrial fibrillation is associated with substantial mortality and 
morbidity.It is caused by many cardiac and non cardiac conditions.AF 
coexists with common cardiovascular conditions ,such as 
hypertension,heart failure,coronary heart disease and diabetes 
mellitus,and with an increasing older general population af will become 
an increasing health care burden. 
AF is increasing in incidence and prevalence.. The estimated 
prevalence of AF in general pop[ulation is 0.4%..The prevalence and 
incidence increases with advancing age,affecting approximately 5% of 
individuals older than 65 years and nearly 10% of those aged older than 
80 years.  In the Framingham study, yearly incidence rates for persons 
age 50 – 59 were approximate 1 – 9 and 0 – 9 per 1000 person years in 
men and women respectively. 
Over 38 years of follow up, the Framingham study found an over 
all incidence rate of approximately 3 per 1000 years in men and 2 per 
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1000 years in women aged 55 – 64 years.  The incidence of AF doubled, 
for every decade increment in age in the Framingham heart study cohort.   
Men are at moderately higher risk of AF than women, however the 
onset of AF in women occurs later in life. 
Prognostically the prevalence of AF is associated with five-fold 
increase in morbidity risk and a two-fold increase in mortality risk.  Most 
complications and Death associated with AF are due to complications 
associated cerebrovascular embolic events. 
Pharmacological treatment modalities form the mainstay of 
treatment. Recent research has highlighted new approaches to both 
pharmacological and non pharmacological management strategies.Newer 
antiarrhythmic agents have been developed and others are being 
evaluated for their potential use in atrial fibrillation. 
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AIM OF STUDY 
1. To analyse the etiological factor, clinical presentation and 
complications of 50 cases of Atrial fibrillation in Government 
Stanley Medical College Hospital, Chennai-1. 
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REVIEW OF LITERATURE 
HISTORY 
Perhaps the earliest description of atrial fibrillation is in The 
Yellow Emperor's Classic of Internal Medicine (Huang Ti Nei Ching Su 
Wen). The legendary emperor physician is believed to have ruled China 
between 1696 and 2598 BC. The poor prognosis associated with chaotic 
irregularity of the pulse was clearly acknowledged by most of the ancient 
physicians, but in recorded history, William Harvey in 1628 was probably 
the first to describe "fibrillation of the auricles" in animals.  
In clinical practice and with the aid of Laennec's recently invented 
stethoscope, Robert Adams reported in 1827 the association of irregular 
pulses with mitral stenosis; in 1863, Etienne Marey published a pulse 
tracing from such a patient. Other early descriptions of atrial fibrillation 
and its importance were published early this century by Sir James 
Mackenzie and Heinrich Hering.  
The discovery of the therapeutic properties of digitalis leaf 
(Digitalis purpurea) in 1785 by William Withering brought some relief to 
patients with severe heart failure. It is interesting that Withering recorded 
a patient who had a weak, irregular pulse that became "more full and 
more regular" after five draughts containing Fol Digital Purp oz iv. In 
1935 Jean Baptiste Bouilland said that he considered digitalis to be "a sort 
of opium for the heart."  
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The main diagnostic breakthrough was the invention of the 
electrocardiograph by William Einthoven in 1900. A close friend of 
Einthoven, Sir Thomas Lewis at University College Hospital, London, 
was the first to record an electrocardiogram in a patient with atrial 
fibrillation.  
The exact mechanisms and importance of atrial fibrillation 
remained controversial (Lewis and Mackenzie had disagreed about these 
issues) until 1970, when Bootsma and coworkers, with the aid of 
computers, concluded that the totally irregular response of the ventricles 
was due to the effect of "randomly spaced atrial impulses of random 
strength reaching the atrioventricular node from random directions."  
The epidemiological importance of atrial fibrillation as an 
important precursor of cardiac and cerebrovascular death was investigated 
in detail in the Framingham study by William Kannell and colleagues in 
1982. Over the past 10 years, awareness has increased of the hazards of 
sustained non-rheumatic atrial fibrillation and the benefits of prophylaxis 
against thrombosis in preventing cerebral thromboembolism.  
EPIDEMIOLOGY 
Atrial fibrillation is common in the community, affecting up to 5% 
of people aged 75 or over. It is a major reason for emergency admissions 
and cause of cardiovascular deaths. Thus most clinicians in hospital and 
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general practice will participate in managing such patients. As the 
prevalence of the condition increases with age, atrial fibrillation will 
become increasingly common in the increasingly aging population.  
Epidemiological studies have shown that atrial fibrillation is fairly 
uncommon in people aged under 50 years but is found in 0.5% of people 
aged 50-59, increasing to 8.8% at age 80-89. Furthermore, the arrhythmia 
may be either chronic or paroxysmal. In the Framingham study, 
hypertension, cardiac failure, and rheumatic heart disease were the 
commonest precursors of atrial fibrillation. Up to a third of patients with 
atrial fibrillation, however, may have idiopathic or "lone" atrial 
fibrillation, where no precipitating cause can be identified and no 
evidence of structural heart disease exists.  
Atrial fibrillation is more common in hospital practice than in 
general practice, being present in up to 7% of emergency medical 
admissions to district general hospitals. The commonest causes in 
Western countries include coronary heart disease, hypertension, and 
rheumatic and non-rheumatic valve heart disease. The commonest 
presenting features included heart failure, stroke, chest pain (including 
myocardial infarction or angina), and respiratory diseases. By contrast, in 
developing countries rheumatic heart disease is by far the commonest 
cause of atrial fibrillation 
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PATHOLOGY 
The incidence of AF is increased with age and is prevalent in those 
aged 60 or greater.  Microscopic and Macroscopic alternation in the atria 
begin in the 1st year of life.  By 4th / 5th decades small fat spots appear in 
the right atrium in the region of AV-node and septum.  These changes 
associated with aging will result in loss of myocardial fibers and fatty 
metamorphosis, and connective tissue and Focal hemorrhages in sinus 
node and Atrial Structures.1 
One of the most Important pathological study of Atria in patients 
with AF was done by Davies and Pomerance.3  In nearly 75 patients 
chronic AF there was sinus node muscle loss, internodal tract muscle loss 
and Atrial dilatation.  In case of Rheumatic heart disease the LA is 
enlarged in almost all cases.  In some case of tight mitral stenosis Aschoff 
bodies were found with in the Atrial myocardium.  In other cases spinde 
shaped, or triangular scar lying between the muscle bundles and 
surrounding blood vessels represent the healing of Aschoff bodies. 
MECHANISM OF ATRIAL FIBRILLATION 
The basic mechanism 
Two chamber concept 
         In an electrophysiological scene the heart consist of only two 
chambers.  One formed by the atria and the other formed by the 
ventricles. 
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The two electrophysiological chambers are separated from each 
other by an electrically inert conductions barrier. Conduction barrier 
formed by the fibrous AV-ring. Communication across the barrier under 
normal circumstances is only possible through the specialized conduction 
system formed by the AV-nodes, bundle of his, the bundle branch and 
their ramifications.  
Each chamber is activated by single, coordinated, uniform and 
progressive excitation process, which effects a total and almost 
simultaneous depolarization of the chambers.  All the fibers are rapidly 
brought to the same state of excitability; consequently, the fibers of the 
chamber will at any given movement be in the same or almost the same 
electrophysiological state. 
They will all be in a state of excitability or all in a state of potential  
responsiveness, and when all the fibers of a chamber are uniformly in one 
state, they are said to be in phase with each other.  In myocardial 
fibrillation, the single, uniform activations process is lost and the phase 
state is transformed into a complex out of state.  A physiological 
fragmentation tissue islet in varying states of refractoriness, excitation 
and responsiveness occur.3  
The predisposition to and development of the state is favoured by 
the alternation of the fundamental event. 
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1. Uneven recovery of the chamber an out of phase state.  Where 
one part of the chamber is responsive and the other part of the 
chamber is refractory a case of physiological asymmetry. 
2. Premature stimulation of the chamber by an impulse that 
originates in or is induced into, the chamber before activation or 
recovery is complete. 
THE GENESIS OF PHYSIOLOGICAL ASSYMETRY 
The development of physiological asymmetry with in the biatrial 
chamber is favored by3 
a) Mode of atrial activation 
b) Prolongation of conduction 
c) Unequal conduction 
d) Increase in chamber size 
e) Chamber asymmetry 
f) Aberrancy in refractoriness 
g) Unequal refractory period 
a. Mode of Atrial Activation 
Activation of the actual chamber occurs longitudinally and by 
contiguity, spreading from its point of origin in the SA node to engulf the  
whole chamber.  Thus with longitudinal form of atrial activation proximal 
part are activated before the distal.  This sequential and longitudinal form 
of activation thus favors an out of phase state and hence induces atrial 
fibrillation. 
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Prolongation of Conduction 
A prolongation of conduction time when associated with long 
activation, increase the initial and terminal discrepancy. 
UNEQUAL CONDUCTIONS 
Unequal conduction c in the bit actual chamber will also potentiate, 
simple out of phase due to the difference in intramural terrain and disease 
process such as local ischaemia. 
INCREASE IN CHAMBER SIZE 
The larger the size of the chamber, the greater the potential out of 
phase state and more readily will fibrillation be initiated and maintained.  
As it is common in mitral regurgitation / tricuspid regurgitation which are 
associated with mamixal left atrial enlargement. 
CHAMBER ASSYMETRY 
The bilateral chamber is asymmetric and the pacemaker is 
eccentrically placed.  Consequently, activation, recovery occurs soon at a 
point close to the pacemaker, then a point remote from the pacemaker.  
This bizarre or assignment shape of biatrial chamber will therefore in 
presence of long activation predispose toward the unequal recovery of the 
chamber.4 
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ABREVATION OF REFRACTORINESS 
A short refractory period when associated with a long or relatively 
long conduction time will also predispose to the maintenance of 
fibrillation. 
UNEQUAL REFRACTORINESS 
Unequal refractoriness of the biatrial chamber will also aggravate 
the terminal out of phase discrepancy and predispose to atrial fibrillation. 
SHORTENED REFRACTORY PERIOD 
Any condition, which shortens the refractory period, will facilitate 
the perpetuation of fibrillation. 
The following condition shorter the refractory period. 
1. Acetyl choline 
2. Vagal stimulation 
3. Low K+ Concentration 
4. High K+ Concentration 
5. Digitalis toxicity 
All the factors facilitate the precipitation and perpetuation of 
fibrillation.  AF is easily maintained in cases of TR / MR due to large 
atria. 
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CAUSES OF PREMATURE ATRIAL STIMULI 
The development of an out of phase state with in the biatrial 
chamber predisposes to the prescription of fibrillation by premature 
stimuli. 
Those are of 4 basic sources of premature stimuli. 
1. Atrial Extra systoles 
2. Atrial Tachycardia 
3. Reciprocal stimuli 
4. Circus movement 
Atrial extra systole are premature impulses which arise from an 
ectopic atrial pacemaker and then particularly if multiple and multifocal 
in origin will favour the initiation of fibrillation.5 
ATRIAL TACHYCARDIA 
Tachycardia shortens the refractory period but with very fast rates, 
the refractory period is reduced to a critical level, when it cannot shorten 
any further.  It then occupies virtually the complete diastolic interval. 
When this occurs, successive impulses will tend to fall in the terminal out 
of phase period and may then initiate fibrillation.6 
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RECIPROCAL STIMULI 
A premature stimulus of atria is also facilitated by the presence of a 
bypass within the AV conduction pathway.  The rapidly returning 
reciprocal impulses constitute an early stimulus to the bi-atrial chamber 
and may consequently initiate the fibrillation in the WPW syndrome and 
LGL syndrome6. 
CIRCUS MOVEMENT STIMULUS 
Circus movement stimuli a form of activation where in the 
excitation wave travels in a circular path around the bi-atrial chamber. 
The Phenomenon occurs when the time taken for the excitation 
wave to travel around the bi-atrial chamber exceeds the refractory period.  
When this comes about the tissue ahead of the excitation front is always 
fully responsible and excitation is there by precipitated as a circular 
movement around the atria.1 
The mechanism is facilitated by the association of a long 
conduction time and short refractory period.  A circus movement may be 
responsible in some cases of atrial flutter. 
Atrial flutter frequently precedes AF.  The flutter constitute a 
source of early stimulation by virtue of a circus movement of rapidly 
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repitive stimulation and the flutter rate increases further before the 
conversion to Atrial Fibrillation.6 
The aforementioned principle indicates that in the presence of 
longitudinal activation, the initiation of AF is formed by enlarged of bi-
actual chamber, prolongation of conduction, inequality of conduction, 
decrease in refractory period. 
BASIC MECHANISM OF ATRIAL FIBRILLATION 
It is recognized that AF is initiated through one of several triggers.  
These triggers induce premature atrial complex or repetive activity 
occurring in the atrial body or in the myocardial sleeve of the pulmonary 
Vein.7 
These triggers can initiate a self-sustained Atrial fibrillation in a 
vulnerable substrate (Focal trigger) or continue to fire and drive the atria 
in atria fibrillation by means of Fibrillatory conduits. (Focal driver) 
 There is recent evidence that the focal trigger is in the pulmonary 
Vein.7 
MULTIPLE WAVELETS 
It was proposed that atrial Fibrillation was caused by multiple 
random recentrant wavelets. 
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MOTHER ROTOR THEORY 
A rotor is defined as stably rotating pathway of reaction that 
surrounds a pivotal point.  A curved wave front radiates from the rotor to 
the surrounding tissues.7 
ECG MANIFESTATION OF ATRIAL FIBRILLATION 
Atrial Fibrillation is characterized electrocardiographically by 
grossly disorganized atrial actually that is irregular in respect to both rate 
/ rhythm.  There is no visually discernible timing pattern to the atrial 
electrical activity on the surface ECG. 
Atrial fibrillating waves are best seen in VI, LII and LIII. 
A fine atrial fibrillation waves virtually no imprint on the base line 
(“Straight line AF”).  Coarse AF – fibrillatory waves are the size of 
respectable flutter waves, but are irregular. 
One of the most challenging aspects in ECG is the distinction 
between aberrant intra ventricular conduction and Ventricular ectopy in 
the presence of Atrial Fibrillation. 
Aberrant conduction tends to occur when a long ventricular cycle is 
followed by a short cycle.  This long short cycle sequence with the short 
cycle terminated by an aberrantly conducted beat is called ASHMAN’s 
PHENOMENON.   
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A series of short cycle if short enough may generate runs of 
consequent aberrant beats initiating VT. 
Thus additional criteria for distinction between aberrancy and 
ectopy are required.  In general an initial QRS Vector similar or identical 
to that of narrow QRS and a typical RBBB pattern in association with a 
long-short cycle sequence strongly favours aberrancy over ectopy. 
LBBB aberrancy also occurs but is less common.  Atrial fibrillation 
alters intraventricular conductions only through the following 
mechanism. 
1. Functional bundle – branch block / Aberrancy. 
2. Loss of Delta waves in WPW with normal pathway 
conduction during AF. 
In patients with pre existing bundle branch block who develop AF 
with rapid ventricular response, the distinction from VT may be different.  
AV CONDUCTION IN AF 
Conduction of the impulses from the fibrillating atria may be  
complicated by  
1. Physiological 2º A V – block  
2. High Degree A V – block  
3. Complete A V – block  
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AF WITH PHYSIOLOGICAL 2º AV – BLOCK  
A – V node offers block because of its inherent refractory period.  
When AV node is bombarded by a large number of stimulus from the 
atrial, many, which fall on the refractory period of the AV node are 
blocked, and conduction occurs only when the node recovers.  Because of 
this irregularity of the atrial impulses, the block also occurs irregularly 
and so the QRS complexes are placed at irregular intervals.  In this type 
of block the vent of block the ventricular rate is between 120 – 180 / mt. 
At times, the distributed pattern of the QRS complex in atrial 
fibrillation suggests a wenckeback form of AV conduction.  This is 
suggested by a progressive diminution in RR interval followed by a long 
pause.8 
AF WITH HIGH GRADE AV – BLOCK 
This is characterized by idionodal (or) idioventricular escape beats 
that occurs regularly.  Hence the long interval of QRS complexes during 
fibrillation remains constant. 
AF WITH COMPLETE HEART BLOCK 
Characterized by slow and regular ventricular rate.  These beats are 
due to idionodal or idioventricular rhythms.  In the former the QRS 
complexes are narrow, while in the latter the complexes are wide. 
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TYPES OF ATRIAL FIBRILLATION 
Fast AF : When the ventricular rate is more than 120 / mt. 
Show AF : When the QRS Complexes occur at the rate of 60 – 120 
/mt 
These terms are misnomers, service the atrial rate is very high in 
both  case and the term fast and slow here applies to the ventricular rate. 
AF WITH REDUCED VENTRICULAR RATE 
This occurs in 
1. Complete heart block with idionodal / idioventricular 
rhythm. 
2. After administration of drugs like verapamil. 
3. Functional or Ventricular Tachycardia. 
DURATION 
PAROXYSMAL 
PERSISTENT 
PERMANENT 
Basic classification of the types of atrial fibrillation (AF) 
Lone AF  
Lone AF occurs in the absence of cardiac or other conditions 
predisposing to AF. 
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Acute AF 
Acute AF generally refers to AF lasting less than 48 hours. 
Paroxysmal AF 
Paroxysmal AF generally is characterized by recurrent, transient 
episodes that revert to sinus rhythm spontaneously or with treatment. 
Persistent AF 
Persistent AF does not convert to sinus rhythm with out 
intervention or cardioversion. 
Permanent AF 
Permanent AF is persistent despite cardioversion. 
 
 
 
 
 
 
Paroxysmal* 
Duration less than 
seven days, and 
terminates 
spontaneously 
Persistent* 
Duration greater than 
seven days, and would 
last indefinitely unless 
cardioverted 
Permanent 
Duration greater 
than seven days, and 
sinus rhythm not 
possible 
Atrial 
fibrillation 
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AETIOLOGY OF ATRIAL FIBRILLATION 
CVS disorders 
1. Rheumatic heart disease 
2. Coronary artery heart disease 
3. Systemic Hypertension 
4. Cardiomyopathy 
a. Dilated 
b. Hypertrophic 
5. Congenital heart disease 
a. Atrial septal Defect 
b. Leutembackers syndrome 
c. Tricuspid Artesia 
d. Ebsteins anomaly 
6. Sick Sinus 
7. Diffuse myocardial disease – myocarditis 
8. Pericardial disease 
a. Constrictive pericarditis 
b. Pericardial effusion 
9. Pre – Excitation syndromes 
a. WPW 
b. LGL 
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10.  Syphilitic heart disease 
11.  Bacterial Endocarditis 
12.  Atrial myxoma 
13.  Metabolic 
a. Hyperthyroidism 
b. Hyperkalemia 
c. Uremia 
NEUROLOGIC DISEASE 
Meningitis 
Emotional Stress 
MISCELLANEOUS CAUSES 
During Anesthesia 
Drugs & chemicals 
a) Alcohol 
b) Smoking 
c) Coffee 
d) Digitalis 
e) Adrenaline 
Vomiting spells 
Lone Atrial Fibrillation  
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RHEUMATIC HEART DISEASE 
Causes of Mitral, Tricuspid Valve disease is frequently associated 
with AF because, 
1. Enlargement of Atria 
2. Increased Atrial conduction time 
3. Difference refractoriness of Atrial myocardium 
4. Atrial ectopic 
Rheumatic heart disease especially mitral stenosis is particularly 
important as it increases the risk of embolisation in patients with chronic 
AF 5 fold.  Transthoracic echo may show left atrial thrombus, but 
transesophagial Echo is more sensitive than this.9 
CORONARY ARTERY HEART DISEASE 
CAHD is the most common cause of AF in western countries.  In 
addition fast ventricular rate due to fibrillation may cause angina, leading 
to cardiac ischaemia and heart failure.1 
AF may complicate MI and as a marker of extensive myocardial 
infarction and poor prognosis.  If it occurs within 24 hours if an infarct it 
is usually self-limiting.  AF is also a marker of underlying ventricular 
dysfunction.  Many years after MI ventricular scaring and dilatation 
predispose to AF / CCF. 
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Hypertensive heart disease 
Hypertension accounted for about 1/3 of the cases in Framingham 
study.  Hypertension contributes to the complication of stroke.15 
AF may be due to LA dilatation, which occurs in SHT and 
decreased LV compliance.  In additions SHT is associated with CAHD 
which is an add on feature for AF. 
Congestive Cardiac Failure 
CCF from any cause may predispose to AF.  This favoured by 
associated enlarged atria, and the consequent distention of atrial walls. 
Congenital heart Disease 
AF is common in two forms of congenital heart disease – ASD, 
Ebsteins anomaly. 
Cardiac Surgery 
AF is the most frequent atrial arrhythmia noted after cardiac 
surgery.  Patients undergoing CABG is one of the group to have one 
episode of AF in the post OP period.  Post OP discontinuation of Beta 
blockers taken regularly before surgery increases the risk of AF. 
Hyperthyroidism 
AF is not uncommon in thyrotaoxicosis. 
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This is an important curable cause of AF.  About 10 – 15% of 
patients with untreated thyrotoxicosis develop AF.  It is more in males, 
and increased with age.   
Thyroid affects the circulatory system and myocardium.  There 
appears to be an interaction between the excess thyroid hormone and 
catacholamine action, including potentiation of catacholamine effects and 
increase in number of cardiac Beta-receptors.3 
NEUROGENIC CAUSE OF AF 
AF is facilitated by increased sympathetic tone.  Atrial refractory 
period is decreased by Acetylcholine. 
Adregenic form of AF has also been described the characteristic 
are: 
1. Onset during day time 
2. Preceded by emotional stimulus 
3. Exercise 
EXCESS ALCOHOL INTAKE 
         AF due to an excess alcohol often occurs after holidays or at week 
ends. (Holiday heart Synd) 
         Alcohol thus precipitates AF in health people and chronic excess 
intake of alcohol can be associated with a dilated heart. (Alcohol heat 
muscle disease) and AF.  
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PNEUMONIA 
Pneumonia is commonly associated with AF in 7% cases of 
pneumonia as a precipitation of AF and occurs predominantly in elderly 
patients. 
IDIOPATHIC / LONE AF 
Some patients with AF have not predisposing factor or Cardiac 
lesion.  The condition in this patient is classified as lone or idiopathic AF. 
FAMILIAL AF 
Extremely uncommon, is seen in relatively young age less than 20 
years.  The gene responsible for AF was located on chromosome 10q in 
the region of 10q 22. 
CLINICAL FEATURES OF AF 
The haemodynamic consequences of AF are due to two factors. 
1. Loss of Atrial systole – may impair Ventricular filling in the 
non-complaint ventricle  e.g.: AS / LVH 
2. A rapid ventricular rate will encroach upon the diastolic 
filling period of the Left ventricle and the diastolic flow time 
of the coronary time. 
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ATRIAL CONTRACTION 
IMPORTANT 
 DIASTOLIC 
CONTRACTION 
IMPORTANT 
Aortic Stenosis  Mitral stenosis 
Hyp. Cardiomyopathy  CAHD 
SHT / LVH  DCMP 
Restrictive Cardiomyopathy  WPW syndrome 
DCMP / CCF  Nodal Conduction 
 
The symptoms are: 
1. Palpitation  
2. Dyspnoea 
3. Fatigue 
4. Angina 
5. Presyncope 
6. Syncope 
Physical Findings 
Pulse is irregularly irregular. 
Absence of ‘a’ waves in the “JVP” 
An Apex – radial pulse deficit appears, as each contraction may not 
be sufficiently strong to transmit an arterial pulse to the peripheral artery. 
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Cardiac auscultation will reveal the Variable intensity of S1 due to 
fluctuating ventricular filling period and sign of underlying heart disease 
like MS. 
COMPLICATIONS 
Heart failure 
The sudden onset of AF may precipitate overt hear failure 
particularly of LV functions is already compromised by co-existing heart 
disease.  In HF patients AF may be a marker of increased mortality and 
may also enhance the substantial risk of embolisation. 
THROMBOEMBOLISATION 
AF predisposes to the formation of intracardiac thrombus, which 
may result in stroke, Thromboembolisastion.  The commonest site of 
thrombus is LA appendage.  RA thrombus with pulmonary embolisation 
is a rare complication. 
STROKE 
The following factors are associated with high risk stroke in 
patients with AF11. 
1. Age > 65 yrs 
2. SHT 
3. RHD 
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4. Prior Stroke / TIA 
5. DM 
6. CCF 
7. LA dimension > 50mm 
INVESTIGATIONS 
ECG 
AF should be documented fully with a conventional 12 lead ECG.  
This may provide a clue to the etiology or electrophysiological features 
that may cause this arrhythmias  e.g. : IHD / LVH. 
It was thought that coarse fibrillating waves favor the etiology of 
RHD or hyperthyroidism while fine fibrillating waves are associated with 
SHT.  This not true. 
A 24 hours holter monitoring may be needed to document 
paroxysmal atrial fibrillation or sick sinus syndrome. 
CHEST RADIOGRAPHY 
A chest X ray is useful in most cases of AF.  In a young patient it 
may provide a clue to congenital heart disease such as ASD. 
X ray film can given information regarding the size of the heart, 
whether the patient has CCF. 
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BLOOD TEST 
Full blood counts: Especially if anticoagulants are indicated 
Urea, Electrolytes  
Thyroid function test 
ESR /ASO – titer – Rheumatic Fever 
MI – Enzyme studies – CPK, CPK-MB, Troponin–T  
ECHO 
An Echo is an important test to obtain in patients with Atrial 
Fibrillation.  It allows the evaluation of Atrial, R/L, Ventricular function.  
Presence of congenital and valvular lesions. 
Transesophageal echo is valuable to investigate atrial thrombi prior 
to cardio version. 
EXERCISE TESTING    
Exercise testing is necessary in some patients with IHD and AF to 
clarify the seriosity of underlying cardiac ischaemia. 
ELECTROPHYSIOLOGICAL STUDY 
In patients with AF due to prexicitation syndrome, 
electrophysiological studies may be needed to document the characteristic 
of conduction from the atria to the ventricles and the presence of 
accessory pathway.  This may lead to a cure of the conduction by 
transcathedral ablation of accessory pathway9. 
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MANAGEMENT OF ATRIAL FIBRILLATION 
Management of AF includes following strategies 
• Identification and treatment of the underlying reversible causes like 
hypoxaemia with acidosis in patients with acute respiratory failure, 
hyperthyroidism and carbon monoxide poisoning. 
• Anticoagulation 
• Attempt to convert it to sinus rhythm and maintain it 
• Attempt to slow the ventricular rate by using AV nodal blocking 
drugs and in drug refractory cases by AV nodal ablation followed 
by placement of a pacemaker while allowing the arrhythmia to 
continue. 
         The following are the recommendations for treatment for Atrial 
Fibrillation. 
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STRUCTURAL HEART DISEASE 
Yes No
Type-
1C
Sotalol
Amiodarone
Dofetelide
LVEP<
40% and
CCF
CAHD
Normal EF
SHT
Amiodaron
e Dofetelide
Saatalol
IVS>1.
4 cm
IVS<1.
4 cm
Amiodarone Propafenone
Amiodarone
Dofetelide
Type - 1A
Amiodaron
e Dofetelide
Type - A
Disopyrami
Dequinidine
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ACUTE TREATMENT OF ATRIAL FIBRILLATION 
Pharmacological cardio version appears to be most effective with 
in 7 days after the AF especially within 48 hours. 
If AF with haemodynamic compromose, ongoing angina – 
electrical cardio version is preferable9. 
If electrical cardio version is fails to restore, sinus rate, pre 
treatment with anti arrhythmic like ibutulide will decrease the atrial 
defibrillation threshold. 
GUIDELINES FOR THROMBOTIC THERAPY IN AF 
Based on a guideline formed by the 6th consensuses Conference of 
Anti Thrombotic therapy of the American College of Chest Physicians. 
AF with 
preexcitation 
WPW 
PROCAINAMIDE 
AMIODARONE 
DISOPYRAMIDE 
AF in 
pregnancy 
For rate control B-
blockers Cal. 
Channel blocker 
Acute conversions 
quinidine 
fleclainide 
AF in  
HOCM 
DISOPYRAMIDE 
AMIODARONE  
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HIGH RISK 
H/o Prior stroke / TIA   Anti-coagulants 
Poor LV function    Maintain INR 2 – 3 
Age 71 years     + Aspirin 
Rheumatic Mitral Valvular Disease 
MODERATE RISK 
65–75 Yrs DM/CAHD        Anti coagulant maintain INR .5– 2.5  
LOW RISK 
< 65 years     Aspirin alone 
No clinical / ECHO 
Evidence of CVS disease 
ASPIRIN Vs ANTI COAGULATION IN PATIENTS WITH HIGH 
RISK CATEGORY OF AF 
SPAF – I trial (stroke prevention in AF) found that Anti 
Coagulation was significantly more effective than aspirin in decreasing 
the rate of all strokes and other cardiovascular events. 
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ANTI COAGULATION COMPARED WITH ANTI 
COAGULATION WITH ASPIRIN 
NASPEAF (National Study of Prevention of Embolism in AF) 
compared the efficacy of Aspirin + anti coagulation (Target INR 1.5 – 
2.4) Vs anti coagulation targeted at INR (2 – 3) preliminary reports 
suggested that the former is more effective than the later. 
RATE Vs RHYTHM CONTROL 
PIAF trial (Pharmacological intervention in AF) has come with the 
conclusion. 
1. Quality of life is same in both 
2. Exercise tolerance is better in rhythm controlled patients. 
3. Hospital admission and adverse effects are high in rhythm 
controlled patients. 
Non-pharmacological methods for treating atrial fibrillation 
• Rhythm control strategies 
• Surgical ablation 
• Catheter ablation 
• Single and multiple atrial pacing 
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• Atrial defibrillators 
• Rate control strategies 
• AV node function modification 
• AV node ablation and permanent pacing 
CHADS2 INDEX (Stroke Risk in Patients with Nonvalvular AF Not 
Treated with Antiocoagulation) 
CHADS2 risk   Score 
Cardiac tailure   1 
Hypertension   1 
Age > 75 Yrs   1 
Diabetes mellitus   1 
Prior stroke or TIA  2
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Risk category and recommended anti thrombotic therapy according 
to CHADS2 score 
CHADS Score Risk category Recommended anti thrombotic 
therapy 
0 Low Aspirin 81-325 mg PO daily 
1 Moderate Aspirin or warfarin 
2 Moderate Previous CVA/TIA/embolism/ 
- Yes = Warfarian 
- No = Aspirin or warfarian 
3 High 
4 High 
5 High 
6 High 
Warfarin (INR 2.0 – 3.0) 
 
Appropriate anticoagulation in various AF populations 
Patients features Antithrombotic therapy 
Age<60 yr, no heart disease (lone 
AF) 
Aspirin (81-325 mg/d) or no 
therapy 
Age<60 yr, heart disease but no 
RFs 
Aspirin (81-325 mg/d) 
Age 60-74 yr, no RFs Aspirin (81-325 mg/d) 
Age 65-74 yr with diabetes 
mellitus or CAD 
Oral anticoagulation (INR 2.0-3.0) 
Age 75 yr or older, women Oral anticoagulation (INR 2.0-3.0) 
Age 75 yr or older, men, no other 
RFs 
Oral anticoagulation (INR 2.0-3.0 
or aspirin (81-325 mg/d) 
Age 65 or older, heart failure Oral anticoagulation (INR 2.0-3.0) 
LV ejection fraction <35% or 
fractional shortening <25% and 
hypertension 
Oral anticoagulation (INR 2.0-3.0) 
Rheumatic heart disease (mitral 
stenosis) 
Oral anticoagulation (INR 2.0-3.0) 
Prosthetic heart valves; prior 
thromboembolism 
Oral anticoagulation (INR 2.0-3.0 
or higher) 
Persistent atrial thrombus on TEE Oral anticoagulation (INR 2.0-3.0) 
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Algorithm for ANTITHROMBOTIC THEARPY IN NON 
VALVULAR AF 
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MATERIAL AND METHODS 
This study was conducted at Government Stanley Medical College 
Hospital, Chennai during the period of January 2007 to June2007.  Fifty 
cases of patients admitted with atrial fibrillation were recorded.  No 
patient had been counted to if he/she got admitted again after discharge.  
Paediatric age group (13 Yrs and Less) was not included in this study. 
The Diagnosis of AF: 
This was made on clinical grounds and confirmed by ECG / 
ECHO. 
Clinical Grounds: 
Irregularly irregular pulse: 
If the patient was not in failure, he or she was exercised and the 
persistence of the irregularity noted. 
Pulse deficit: 
         Simultaneous counting of the pulse rates by one observer and the 
heart rate by another for one full minute. 
         Absence of “a” waves in JVP. 
         On Auscultation varying intensity of SI. 
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ECG Recording 
        A 12 lead ECG was taken for all the cases.  It was standardized to 
produce a deflection of 10 mm/1 mv input and paper speed was set at 25 
mm/Sec.  The ECG features of AF are: 
1. Absence of regular rhythm / p waves. 
2. Atrial Activity reflected by a variable irregularity 
compounded deflection forming the base line “f” waves.  
3. Marked variation in ‘RR’ interval. 
4. Variation in QRS complex configuration in ECG. 
Other findings like Ventricular Enlargement RVE, RBBB, 
evidence of ischaemia/infarction also noted. 
In all cases complete history was taken and general examination 
done.  Further the patients was subjected the investigations according to 
the suspected etiology. 
Rheumatic Heart Disease 
1. Features of RHD 
2. Features of CCF 
3. Presence of Valvular heart disease 
4. Features of Infective Endocarditis  
5. Chest X-Ray PA view 
6. CT Scan for any embolic complication 
7. ECHO 
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CORONARY ARTERY HEART DISEASE: 
1. History / ECG 
2. HT / DM 
3. Auscultation for S3 / S4 
4. Ophthalmic Examination 
5. Chest X-ray PA view for cardiomegaly / Pulmonary 
congestion 
6. Serum enzymes – CPK – CPK-MB in case of infarction 
Systemic Hypertension: 
1. Blood Pressure 
2. Fundus examination 
3. ECG for LVH, LVE, LAE 
4. Chest X-ray PA view – Cardiomegaly 
5. Urine analysis 
6. Urea – Creatinine – Sugar 
CHEST X-RAY PA VIEW 
Chest X-ray PA view was taken and evaluated for evidence of 
valvular heart disease, congenital heart disease, pericardial effusion, 
COPD, pneumonia, etc., 
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ECHO 
M-mode, 2 D ECHO was done for all the patients and the presence 
of thickening of the valves, calcification, and valve closure were noted.  
The size of the valve ring and the chamber of the heart were noted.  The 
presence of clot in the atria/atrial appendage was also noted. 
Diagnosis of Complication of AF 
         AF complicating CCF, complete history, examination done.  ECG, 
Chest X-ray PA for cardiomegaly and pulmonary congestion.  ECHO 
evaluation of ventricular function was noted. 
AF complicating stroke patient neurological examination done.  CT 
scan brain taken and the feature were noted.  The presence of thrombus in 
atria using ECHO noted. 
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OBSERVATIONS 
 
 
TABLE 1 
AETIOLOGY 
CAUSES NUMBER OF 
CASES 
% 
Rheumatic Heart Disease 30 60% 
Ischaemic Heart Disease 8 16% 
Cardiomyopathy (Dilated) 8 16% 
Syst hypertension 2 4% 
Misc. Holiday heart synd 2 4% 
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TABLE 2 
AGE DISTRIBUTIONS 
CAUSES NUMBER OF CASES % 
13 – 20 -- 0% 
21 – 30 10 20% 
31 – 40 15 30% 
41 – 50 9 18% 
51 – 60 13 26% 
61 and above 3 6% 
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TABLE 3 
SEX DISTRIBUTIONS 
AETIOLOGY MALES FEMALES 
Rheumatic Heart Disease 19 11 
Ischaemic Heart Disease 5 3 
Cardiomyopathy -- 8 
Systemic Hypertension 1 1 
Miscellaneous 2 -- 
% 54% 46% 
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TABLE 4 
AGE AND ETIOLOGICAL INCIDENCES 
AGE AETIOLOGY 
RANGE MEAN 
Rheumatic Heart Disease 21 – 60 Yrs 35.7 yrs 
Ischaemic Heart Disease 50 – 67 Yrs 58.3 yrs 
Cardiomyopathy  42 – 58 Yrs 52 yrs 
Systemic Hypertension 44 – 52 Yrs 48 yrs 
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TABLE 5 
TYPES OF VALVULAR LESION CAUSING RHEUMATIC 
HEART DISEASE WITH ATRIAL FIBRILLATION 
Valvular Lesion Number of cases % 
Rheumatic M.S. 11 37% 
MS + MR 15 50% 
MS + MR + AS + AR 4 13% 
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TABLE 6 
CLINICAL MANIFESTATION OF ATRIAL FIBRILLATION 
Clinical 
Manifestation 
Number of cases % 
PALPITATIONS 40 80% 
DYSPNOEA 30 60% 
ANGINA 7 14% 
FATIQUE 5 10% 
SYNCOPE 4 8% 
 
This table is taken into consideration the fact that persons with 
palpitation also has co-existing other clinical manifestation like 
Dyspnoea/Angina. 
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TABLE 7 
LA SIZE IN PATIENTS WITH RHD WITH ATRIAL 
FIBRILLATION 
LA SIZE NUMBER OF 
CASES 
% 
3 – 3.5 cm 2 6% 
3.5 – 4 cm  4 14% 
> 4 cm 24 80% 
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TABLE 8 
COMPLICATION OF ATRIAL FIBRILLATION 
COMPLICATION NUMBER 
OF CASES 
% 
Precipitation of cardiac failure  40 80% 
Stroke (Thromboembolic Complication) 3 6% 
Angina 7 14% 
 
Atril fibrillation per se does not cause cardiac failure in a majority 
of case but it precipitates failure in a heart which is compromised 
haemodynamically due to rheumatic heart disease or when the pumping 
action is compromised in case of DCMP and CAHD. 
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DISCUSSION 
ETIOLOGY 
In our study, we found that the commonest etiology causing atrial 
fibrillation was rheumatic heart disease, which constituted 60% of the 
cases followed by dilated cardiomyopathy.  This is in sharp contrast to 
the study by WARREN J.MANNING, STEPHENGORDON (NEJM 
volume 328 March 1993) were hypertension was the commonest etiology 
contributing 46%.  Rheumatic Heart Disease contributes to only 4% of 
the cases.  But our study coincided a study from Ethiopia in which 
rheumataic heart disease contributes about 66% of the cases.  
AGE/SEX DISTRIBUTION 
In our study, we found that the majority of the cases were in the 4th 
and 5th decade, but in Framingham study and study by GODTFREDSENJ 
(AF, molndal Sweden: AB hassle 1982) which was common in the 6th 
and 7th decade.  This can be attributed to the fact that rheumatic heart 
disease accounted for majority of the cases in our study.  And also in our 
study there was no major sex difference in the distribution of atrial 
fibrillation. 
In our study atrial fibrillation in rheumatic heart disease occurred at 
a mean age of 35.7 years.  This is low when compared to the Framingham 
study in which the mean age was in the 6th decade. 
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VALVULAR LESIONS IN RHEUMATIC HEART DISEASE WITH 
ATRIAL FIBRILLATION 
In our study, the predominant lesion in rheumatic heart disease 
causing atrial fibrillation was mitral valvular disease.  This correlates well 
with the Framingham study. 
LEFT ATRIAL SIZE IN PATIENTS WITH RHEUMATIC HEART 
DISEASE WITH ATRIAL FIBRILLATION 
In out study, it was found that the majority of the cases of 
rheumatic heart disease with atrial fibrillation had a left atrial diameter of 
greater than 4 cm.  This coincides with the study by SANOOP, 
JOHNSON (INDIAN HEART JOURNAL Sep 2003) in which atrial 
fibrillation was common when the  left atrial size was above 4 cm. 
COMPLICATIONS OF ATRIAL FIBRILLATION 
In our study, the precipitation of cardiac failure was the major 
complication constituting to 80% of the cases.  This is due to the fact that 
atrial fibrillation precipitates heart failure in a haemodynamically 
compromised state as in rheumatic heart disease due to structural 
abnormality and compromise in pumping action in case of DCMP and 
CAHD.  Since the majority of the cases in our study come under the 
above category precipitation of covert cardiac failure was the major 
complication.  Atrial fibrillation per se only contributes little to cardiac 
failure.  The % of stroke was 6%, this correlated with the study by 
p.Peterson and godtfredson (European heart journal Vol.9 No.3 March 
1998). 
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CONCLUSION 
 The Commonest etiology causing atrial fibrillation was 
Rhenmatic heart disease, which contributed to 60% of the 
cases. 
 The majority of the cases of Atrial fibrillation were in the 4th 
or 5th decade. 
 There were no significant sex differences in the distribution 
of Atrial fibrillation but in Dilated cardiomyopathy had a 
predominant female preponderance. 
 Rheumatic heart disease patients with atrial fibrillation had a 
mean of 35.7 years, while patients with ischaemic  heart 
disease had a mean of 58.3 years. 
 In Rheumatic heart disease the predominant lesion causing 
AF was mitral valve lesion. 
 The commonest clinical manifestation causing Atrial 
fibrillation was palpitations followed by dyspnoea. 
 A Left atrial size of >4 cm predisposes to Atrial fibrillation 
in Rheumatic Heart Disease. 
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 The major complication of atrial fibrillation was 
precipitation of cardiac failure. 
 Atrial fibrillation perse does not cause cardiac failure in a 
majority of cases. But it may precipitate overt cardiac failure 
in a haemodynamically compromised heart as in rheumatic 
heard disease and pump failure as in DCMP and CHD. Since 
majority of the cases in the study were rheumatic heard 
disease precipitation of cardiac failure was the major 
complication. 
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CASE REPORT 1 
Name      : Mr. Selvaraj 
AGE / SEX     : 40 / M 
I.P. No.     : 033540 
Address     : Redhills 
Presenting Complaints    :  
Dyspnea     : Yes. For the past 6 months 
Palpitation     : Yes. For the past 6 months 
Chest Pain     : No 
Syncope     : No 
Weakness of limbs    : No 
Fatigue     : No 
Past History       
DM      : No 
HTN      : No 
CAD      : No 
Hyperlipedemia    : No 
COPD/BA     : No 
RHD      : Yes 
Treatment History    :  On irregular penicillin prophylaxis 
General Examination:    
Consciousness    : Conscious  
Pallor, Icterus, Clubbing, Cyanosis,  : No  
Lymphadenopathy: 
Pedal Edema     : Yes 
JVP      : Normal 
Vitals: 
Pulse Rate     : 60/mt    Heart Rate 90/mt 
Pulse Deficit     : 30/mt 
BP      : 90/70 mmHg 
Temperature     : 98.4oF 
Respiratory Rate    : 18/min 
Examination of Systems: 
CVS      : S1-varying intensity 
S2-loud pulmonary component 
No - S3, S4 
Murmurs–Mid-Diastolic and 
Pasystolic murmur in mitral area 
RS      :      Normal vesicular breath sounds 
CNS      : Clinically normal 
Abd      : Soft, hepatomegaly present 
Investigations 
Labs      :  
CBC      : Normal 
RFT      : Normal 
LFT      : Normal 
Sr. Electrolytes     : Normal 
Free T4 and TSH    : 
ECG      : 'P' waves absent, varying RR  
Interval Fibrillatory waves present 
ECHO 
Valvular Abnormality   : Rheumatic Heart Disease,  
       Severe (MS), Mod (MR) 
 
LA dilatation    : LA size 4.8 cm 
LA clot / Vegetation   : No Calcified Mitral valve. EF 42% 
X-Ray Chest    : C-T ratio 60%.  LA Enlarged.  
Right ventricular configuration. MPA 
prominent. Grade I pulmonary venous 
hypertension. 
Diagnosis    : RHEUMATIC MITRAL STENOSIS  
      AND REGUGITATION WITH  
ATRIAL FIBRILLATION. 
CASE REPORT 2 
Name      : Mr. Kannapan 
AGE / SEX     : 55 / M 
I.P. No.     : 026778 
Address     : Washermenpet 
Presenting Complaints 
Dyspnea     : Yes. For the past 2 days 
Palpitation     : No 
Chest Pain     : Yes.  For the past 2 days 
Syncope     : No 
Weakness of limbs    : No 
Fatigue     : Yes.  For the past 1 day 
Past History       
DM      : No 
HTN      : No 
CAD      : No 
Hyperlipedemia    : No 
COPD/BA     : No 
RHD      : No 
Treatment History    : No history of any intake of  
      medications 
General Examination: 
Consciousness    : Conscious  
Pallor, Icterus, Clubbing, Cyanosis,  : No  
Lymphadenopathy: 
Pedal Edema     : No 
JVP      : Raised 
Vitals: 
Pulse Rate     : 68/mt    Heart Rate 94/mt 
Pulse Deficit     : 26/mt 
BP      : 100/70 mmHg 
Temperature     : 98.4oF 
Respiratory Rate    : 18/min 
Examination of Systems 
CVS      : S1-varying intensity   
       S2-heard; S3-heard 
S4-No 
RS      :     Normal vesicular breath sounds 
CNS      : Clinically normal 
Abdomen     : Soft, No organomegaly 
Investigations 
Labs      :  
CBC      : Normal 
RFT      : Normal 
LFT      : Normal 
Sr. Electrolytes     : Normal 
Free T4 and TSH    : Normal 
ECG      :    ST elevation in II, III, AVF  
           ST depression in L1, AVL, V2-V6 
     Varying RR interval 
     Fibrillatory waves seen 
      Controlled ventricular response 
ECHO     :      Severe hypokinesia of inferior wall and  
             LV posterior wall.  EF 40%. No clots. 
X-Ray Chest    : Normal  
Diagnosis : INFERIOR WALL MYOCARDIAL 
INFARCTION WITH ATRIAL 
FIBRILLATION 
CASE REPORT 3 
 
Name      : Mrs. Raggamal 
AGE / SEX     : 50 / F 
I.P. No.     : 033640 
Address     : Bharathi Nagar 
Presenting Complaints 
Dyspnea     : Yes. For the past 5 months 
Palpitation     : No 
Chest Pain     : Yes 
Syncope     : No 
Weakness of limbs    : No 
Fatigue     : Yes.  For the past 6 months 
Past History 
DM      : Known Diabetic for 5 years.  
On T.Glibenclamide  5mg 1 bd 
HTN      : No 
CAD      : No 
Hyperlipedemia    : No 
COPD/BA     : No 
RHD      : No 
Treatment History : Known case of DCMP on Aspirin 
and Digoxin and Frusemide 
General Examination:    
Consciousness    : Conscious  
Pallor, Icterus, Clubbing, Cyanosis,  : No  
Lymphadenopathy: 
Pedal Edema     : Yes 
JVP      : Raised 
Vitals: 
Pulse Rate     : 154/mt    Heart Rate 194/mt 
Pulse Deficit     : 40/mt 
BP      : 90/60 mmHg 
Temperature     : 98.4oF 
Respiratory Rate    : 20/min 
Examination of Systems: 
CVS     : S1-varying intensity   
      S2-heard;  
     S3, S4- No 
     Murmurs–Pansystolic murmur in 
     Mitral area. 
RS : Normal vesicular breath sounds heard.  
Basal crepitations heard 
CNS     : Clinically normal 
Abdomen    : Soft, Hopatomegaly present 
Investigations 
Labs     :  
CBC     : Normal 
RFT     : Normal 
LFT     : Normal 
Sr. Electrolytes    : Normal 
Free T4 and TSH   : Normal 
ECG : Absent p waves/varying RR Interval.  
Rapid ventricular response 
ECHO : Dilated cardiomyopathy. EF 30%. No 
clots.  Moderate MR present 
X-Ray Chest : Cardiomegaly Grade I Pulmonary 
Venous Hypertension  
Diagnosis    :         DILATED CARDIOMYOPATHY 
      WITH ATRIAL FIBRILLATION 
CASE REPORT 4 
Name      : Vasanth 
AGE / SEX     : 67 / Male  
I.P. No.     : 036230 
Address     : Mannadi 
Presenting Complaints    :  
Dyspnea     : Yes. For the past 2 days 
Palpitation     : Yes. For the past 2 days 
Chest Pain     : Yes.  For the past 1 day 
Syncope     : No 
Fatigue     : No.   
Weakness of limbs    :  No. 
Past History       
DM     : Known Diabetic for past 10 years 
HTN      : No 
CAD      : No 
Hyperlipedemia    : No 
COPD/BA     : No 
RHD      : No 
Treatment History    : Oral Metformin 500 mg bid 
General Examination:    
Consciousness    : Conscious  
Pallor, Icterus, Clubbing, Cyanosis,  : No  
Lymphadenopathy: 
Pedal Edema     : No 
JVP      : Raised 
Vitals: 
Pulse Rate     : 80/mt    Heart Rate 110/mt 
Pulse Deficit     : 30/mt 
BP      : 94/60 mmHg 
Temperature     : 98.4oF 
Respiratory Rate    : 18/min 
Examination of Systems: 
CVS      : S1-varying intensity   
       S2-heard;  
S3-heard  
       S4-No 
       Murmur - No 
RS      : Normal vesicular breath sounds.  
       Basal crepitations present. 
CNS      : Clinically normal 
Abdomen     : Soft, No organomegaly 
Investigations 
Labs      :  
CBC      : Normal : CPK-MB raised. 
RFT      : Normal  
LFT      : Normal 
Sr. Electrolytes     : Normal 
Free T4 and TSH    : Normal 
ECG :           ST elevation in V1-V6 Absent p 
waves  Varying RR interval.  Non 
progression of r wave in V1–V5 
ECHO : Regional wall motion 
abnormalitay present.  Severe 
hypokinesia of lower 2/3 of IVS, 
LV anterior wall, LV Apex. EF. 
36% 
X-Ray Chest : Cardiac shadow normal. Round 
glass appearance of both lung 
field seen  
Diagnosis    : ACUTE ANTERIOR WALL 
MYOCARDIAL INFARCTION WITH 
ATRIAL FIBRILLATION 
 
CASE REPORT 5 
Name      : Mr. Sekar 
AGE / SEX     : 27 / M 
I.P. No.     : 020629 
Address     : Thiruvotriyur 
Presenting Complaints 
Dyspnea     : No.  
Palpitation     : Yes. For the past 8 months 
Chest Pain     : No 
Syncope     : No 
Fatigue     : No.   
Weakness of limbs    : No. 
Past History 
DM      : No 
HTN      : No 
CAD      : No 
Hyperlipedemia    : No 
COPD/BA     : No 
RHD :    Known case of Rheumatic Heart    
                                                                        disease on penicillin prophylaxis 
General Examination:    
Consciousness    : Conscious  
Pallor, Icterus, Clubbing, Cyanosis,  :   
Lymphadenopathy: 
JVP      : Raised 
 
Vitals: 
Pulse Rate     : 98/mt     
Pulse Deficit     : 34/mt 
BP      : 100/70 mmHg 
Temperature     : 98.4oF 
Respiratory Rate    : 18/min 
Examination of Systems: 
CVS      : S1-varying intensity   
       S2-Loud; 
S3, S4 – No 
Murmurs-Mid diastolic and pan  
systolic murmurs heard  
RS : Normal vesicular breath sounds 
heard.   
CNS : Clinically normal 
Investigations 
Labs      :  
CBC      : Normal 
RFT      : Normal 
LFT      : Normal 
Sr. Electrolytes     : Normal 
Free T4 and TSH    : Normal 
ECG : Absent p waves/varying RR 
Interval.  Fibrillatory waves 
present.  Rapid ventricular 
response  
ECHO : Rheumatic heart disease Mitral 
stenosis  and mitral regurgitation.  
EF. 56%. No clots.  
X-Ray Chest : Cardiomegaly present 
Straightening of left heart border.  
Rvapex Grade I Pulmonary 
Venous Hypertension 
Diagnosis : RHEUMATIC MITRAL 
STENOSIS AND 
REGURGITATION WITH 
ATRIAL FIBRILLATION 
PROFORMA 
 
CLINICAL PROFILE OF ATRIAL FIBRILLATION 
 
Name      : 
AGE / SEX     : 
I.P. No.     : 
Presenting Complaints   : 
Shortness of Breath    : 
Palpitation     : 
Chest Pain     : 
Syncope     : 
Fatigue     : 
Weakness of limbs    : 
Past History 
DM      : 
HTN      : 
CAD      : 
Hyperlipedemia    : 
COPD/BA     : 
RHD      : 
Treatment History 
 
 
 
General Examination:    
Consciousness    : 
Pallor, Icterus, Clubbing, Cyanosis, Lymphadenopathy : 
Pedal Edema     : 
JVP      : 
 Vitals: 
Pulse Rate     : 
Pulse Deficit     : 
BP      : 
Temperature     : 
Respiratory Rate    : 
Examination of Systems: 
CVS      : S1 S2 S3 S4 
 Murmurs 
RS      : 
Abdomen     : 
CNS      : 
Investigation 
LABS      : 
CBC      : 
RFT      : 
LFT      : 
Sr. Electrolytes     : 
Free T4 and TSH    : 
ECG      : 
ECHO     : 
Valvular Abnormality   : 
LA dilatation     : 
LA clot / Vegetation   : 
X-Ray Chest     : 
DIAGNOSIS    : 
 
ABBREVIATIONS 
 
 SHT   - Systemic hypertension 
 VT   - Ventricular tachycardia 
 RBBB   - Right bundle block 
 LBBB   - Left bundle block 
 CCF   - Congestive cardiac failure 
 DCMP  - Dialated cardiomyopathy 
 TIA   - Transient ishemic attack 
 CVA   - Cerebro vascular accident 
 AF   - Atrial fibrillation 
 CAHD  - Coronary artery disease 
 LV   - Left ventricle 
 LA   -  Left atrium 
 RF   - Risk factor 
 INR   - International normalized radio 
 MS   - Mitral stenosis 
 MR   - Mitral regurgitation 
 AS   - Aortic stenosis 
 AR   - Aortic regurgitation 
 WPW   - Wolf parkinson white syndrome 
 HOCM  - Hypertrophic obstructive cardiomyopathy 
 JVP   - Jugular venous pressure 
 BP   - Blood pressure 
 ECG   - Electro cardiogram 
 CABG  - Coronary artery bypass grafting 
 ASD   - Atrial septal defect 
DM   - Diabetes mellitus 
 LVH   - Left ventricular hypertrophy 
 COPD   - Chronic obstructive disease 
 BA   - Bronchial asthma 
 CVS   - Cardio vascular system 
 RS   - Respiratory system 
 CNS   - Central nervous system 
 CBC   - Complete blood count 
 RFT   - Renal function test 
 LFT   - Liver function test 
 TSH   - Thyroid stimulating hormone 
  
KEY TO MASTER CHART 
 
 N  - Normal 
 PALP  - Palpitations 
 DYS  - Dyspnea 
 FAT  - Fatigue 
 SYN  - Syncope 
 ANG  - Angina 
 JVP  - Jugular venous pressure 
 LA  - Left atrium 
 CM  - Centimeter 
 RHD  - Rheumatic heart disease 
 CVA  - Cerebrovascular accident 
 MS  - Mitral stenosis 
 MR  - Mitral regurgitation 
 AS  - Aortic stenosis  
 AR  - Aortic regurgitation 
 DCMP - Dilated cardiomyopathy 
SHT  - Systemic hypertension 
CAHD - Coronary artery heart disease 
  
 
 
 
 
NORMAL CONDUCTION SYSTEM OF HEART 
 
 
 
 
MULTIPLE FOCI (AREAS) SEND OUT IMPULSES 
WHICH CAUSES THE ATRIA TO FIBRILLATE 
 
